Loading...
XNASCERO
Market cap315kUSD
Dec 23, Last price  
0.05USD
1D
-9.80%
1Q
-46.00%
IPO
-99.49%
Name

Phoenix Biotech Acquisition Corp

Chart & Performance

D1W1MN
XNAS:CERO chart
P/E
P/S
1.24
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
255k
0254,831
Net income
-668k
L+111.61%
-315,547-667,736
CFO
-1m
L+56.68%
-697,109-1,092,247

Profile

Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
IPO date
Oct 06, 2021
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFY
2022‑122021‑12
Income
Revenues
255
 
Cost of revenue
2,841
251
Unusual Expense (Income)
NOPBT
(2,587)
(251)
NOPBT Margin
Operating Taxes
599
(17)
Tax Rate
NOPAT
(3,186)
(234)
Net income
(668)
111.61%
(316)
 
Dividends
Dividend yield
Proceeds from repurchase of equity
(139,354)
180,296
BB yield
75.82%
-79.17%
Debt
Debt current
650
Long-term debt
Deferred revenue
Other long-term liabilities
9,150
9,150
Net debt
174
(179,598)
Cash flow
Cash from operating activities
(1,092)
(697)
CAPEX
Cash from investing activities
180,839
(178,500)
Cash from financing activities
(138,704)
180,296
FCF
26,376
Balance
Cash
476
1,099
Long term investments
178,500
Excess cash
463
179,598
Stockholders' equity
15,693
349,331
Invested Capital
11,206
302
ROIC
ROCE
EV
Common stock shares outstanding
17,896
22,981
Price
10.27
3.64%
9.91
 
Market cap
183,802
-19.29%
227,744
 
EV
183,976
48,146
EBITDA
(2,587)
(251)
EV/EBITDA
Interest
Interest/NOPBT